Overview

Pharmacokinetics of HLD200 in Children and Adolescents With ADHD

Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
This study was designed to assess the pharmacokinetic effects of a single dose of HLD200 (methylphenidate hydrochloride) in children and adolescents with ADHD.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Ironshore Pharmaceuticals and Development, Inc
Treatments:
Methylphenidate